ClinicalTrials.gov
public full text
Public Domain
Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis
The objective of APOLLO is therefore to identify biomarkers associated with the CNS involvement phenotype in early MS patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis#812551
- Electrical Stimulations on Pain, Functional Capacity and Quality of Life in Multiple Sclerosis#1057437
- TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis#1030897
- Effects of A Dual-Task Intervention in Postural Control in Multiple Sclerosis Patients#838675
- COMparison Between All immunoTherapies for Multiple Sclerosis.#363614
Record · ID 840296
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive